SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-19-004755
Filing Date
2019-03-25
Accepted
2019-03-25 16:08:50
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ff12019_biondvaxpharma.htm F-1 3072013
2 CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M ff12019ex23-1_biondvax.htm EX-23.1 2659
3 GRAPHIC img001.jpg GRAPHIC 14288
4 GRAPHIC img002.jpg GRAPHIC 32910
5 GRAPHIC img003.jpg GRAPHIC 34794
6 GRAPHIC img_001.jpg GRAPHIC 8342
  Complete submission text file 0001213900-19-004755.txt   3200584
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: F-1 | Act: 33 | File No.: 333-230484 | Film No.: 19702752
SIC: 2836 Biological Products, (No Diagnostic Substances)